CEO
Rx Valet
Gregory P. Santulli is a healthcare executive and entrepreneur with deep expertise in pharmacy benefit optimization, prescription drug cost containment, and alternative sourcing strategies. He is the co-founder and CEO of Rx Valet, a firm dedicated to delivering transparent, high-impact prescription drug savings solutions for employers, health plans, and public-sector organizations.
Greg has founded multiple successful startups across the healthcare and benefits landscape, with a consistent focus on identifying inefficiencies within traditional delivery and payment models and building scalable, results-driven solutions. His work centers on reducing high-cost brand and specialty drug spend through innovative sourcing strategies, member advocacy, and disciplined financial modeling, while preserving clinical integrity and regulatory compliance.
Under his leadership, Rx Valet has partnered with employers, benefit consultants, third-party administrators, and pharmacy organizations to implement defensible programs that generate measurable savings and improve member experience. Greg is actively involved in program design, implementation strategy, and performance oversight, ensuring that solutions translate from concept to real-world results.
In addition to his operating experience, Greg has served on multiple boards of directors, contributing strategic insight, governance oversight, and growth-oriented leadership to emerging and established organizations.
Greg holds a Bachelor of Science degree from The Ohio State University.
PBM Cost Control That Actually Works: A Three-Year Case Study in Sustainable Pharmacy Savings
Tuesday, March 3, 2026
2:00pm - 3:00pm CT